Altered Immune Cells Rid a Girl of Her Cancer
Altered immune cells rid a girl of her cancer
Filed under: drug treatment centers in pennsylvania
A major drug company, Novartis, is betting on the Pennsylvania team and has committed $ 20 million to building a research center on the university's campus to bring the treatment to market. Researchers say… Continue reading
Alcohol & Drug Treatment – Dysfunctional Family Roles; Family Memebers Adaptation for Survival
Alcohol & Drug Treatment – Dysfunctional Family Roles; Family Memebers Adaptation for Survival – As we learned in the lesson 4, chemical dependence or substance addiction is a family disease. Family members learn to adapt by assuming roles and characterizations that help them deal with the dysfunction in the… Continue reading
Should the Use of Homeopathic Treatments on Children Be Banned?
Question by Gary Y: Should the use of homeopathic treatments on children be banned?
A prominent pharmacy consultant is calling for the Australian Federal Government to ban the use of homeopathic treatments on children.
From the article, “Homeopathy not for children: pharmacist”:-
His comments come after a British parliamentary… Continue reading
Can You Force a 15 Year Old to Enter Drug Rehab (As Their Parent)?
Question by Cassie: Can you force a 15 year old to enter drug rehab (as their parent)?
My wife’s youngest sister is addicted to numerous drugs and openly abuses them. She is only 15. We called a treatment center and they told us that she has to want to… Continue reading
Mice Serve as Personal Stand-Ins in Fight Against Cancer
Mice serve as personal stand-ins in fight against cancer
Filed under: Houston Drug Treatment
And companies are beginning to commercialize them for use in drug development and medical treatment. The Houston company StemMed is helping pharmaceutical companies do clinical trials on the mouse surrogates of patients. Experts caution that it… Continue reading
Synergy Pharmaceuticals Files IND for SP-333, a Developmental Drug for …
Synergy Pharmaceuticals Files IND for SP-333, a Developmental Drug for …
Filed under: drug treatment news 2011
NEW YORK, Sept. 12, 2012 (GLOBE NEWSWIRE) — Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, announced today that an Investigational New Drug (IND) application… Continue reading